Hypertension · 2002 · 69 citations · 40 references
Life SciencesBiochemistryPharmacologyBiochemical PharmacologyMolecular Cell BiologyRedox BiochemistryAntioxidant DefenseLipid MetabolismLipoprotein MetabolismOxidative StressReactive Oxygen SpeciesRedox SignalingAntioxidantsExtracellular Signal-regulated Kinase PathwayLow-density Lipoprotein ParticlesMitogen-activated Protein Kinase CascadesMitogen-activated Protein Kinase PathwaysRedox Regulation Of KinasesRedox-sensitive Signaling PathwaysVascular Smooth Muscle Cell Proliferation
This study investigated mechanisms underlying native low-density lipoprotein (LDL)-stimulated proliferation of human vascular smooth muscle cells (VSMC). Experiments were performed to determine whether native LDL affects reactive oxygen species (ROS) formation and activity of extracellular signal-regulated kinase 1/2 (ERK1/2), and whether redox-sensitive pathways contribute to LDL-induced cell proliferation. Native LDL (100 microg/mL, 24 hours) increased cell proliferation (to 303 to 388% of control, P<0.0001) as determined by [methyl-(3)H] thymidine incorporation. This effect was completely blocked either by the antioxidants N-acetylcysteine, Tiron, or nordihydroguaiaretic acid; the flavin-inhibitor diphenylene iodonium; or superoxide dismutase (all P<0.0001), and partly blocked by ERK-inhibitor PD98059 or meclofenamate (P<0.01). Exposure of VSMC to native LDL for 20 minutes stimulated ROS formation, measured by dichlorodihydrofluorescein oxidation, and increased ERK1/2 activity by 3.1-fold (P<0.001). The latter effect was sensitive to MEK1/2 inhibitor PD98059 and Tiron (P<0.001), and in part to N-acetylcysteine or diphenylene iodonium (P<0.05). These results demonstrate that native LDL induces acute formation of ROS and subsequent activation of redox-sensitive ERK 1/2 mitogen-activated protein kinases, pathways that appear to be important for mitogenic signaling of native LDL in human vascular smooth muscle cells.
40
Prevention of Coronary Heart Disease with Pravastatin in Men with Hypercholesterolemia
James Shepherd, Stuart M. Cobbe, Ian Ford et al. · New England Journal of Medicine · 1995 · 7.5K citations · Full text
William B. Kannel, Philip A. Wolf, Emelia J. Benjamin et al. · The American Journal of Cardiology · 1998 · 2K citations